You have 9 free searches left this month | for more free features.

methylprednisolone and cyclophosphamide

Showing 26 - 50 of 2,306

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Garran, Australian Capital Territory, Australia
  • +12 more
Nov 1, 2023

Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)

Recruiting
  • Mycophenolate Mofetil
  • +2 more
  • Changsha, Hunan, China
    the Second Xiangya Hospital of Central South University
Aug 8, 2022

MEMBRANOUS NEPHROPATHY Trial in Madrid (TACROLIMUS, RITUXIMAB, METHYLPREDNISOLONE)

Completed
  • MEMBRANOUS NEPHROPATHY
  • Madrid, Spain
    Hospital 12 de Octubre
Jan 15, 2020

Systemic Sclerosis, Scleroderma Trial in Chicago (Rituximab, Fludarabine, Cyclophosphamide)

Terminated
  • Systemic Sclerosis
  • Scleroderma
  • Chicago, Illinois
  • +1 more
Aug 10, 2020

Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency Trial in Beijing (Plasma Exchange (PE), Methylprednisolone

Terminated
  • Glomerulonephritis, IGA
  • +3 more
  • Plasma Exchange (PE)
  • Methylprednisolone pulse
  • Beijing, Beijing, China
  • +1 more
Sep 30, 2021

Glomerulonephritis, IGA Trial (Prednisolone, Prednisolone plus Cyclophosphamide)

Not yet recruiting
  • Glomerulonephritis, IGA
  • (no location specified)
Aug 19, 2022

Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Aug 22, 2022

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, ANCA-Associated Glomerulonephritis Trial in Chongqing

Recruiting
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • ANCA-Associated Glomerulonephritis
  • Chongqing, Chongqing, China
    Children's Hospital of Chongqing Medical University
Jul 23, 2023

Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
  • (no location specified)
Aug 23, 2022

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • anti-thymocyte globulin
  • +5 more
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 23, 2020

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • anti-thymocyte globulin
  • +7 more
  • Cleveland, Ohio
    Ireland Cancer Center at University Hospitals Case Medical Cente
Jul 23, 2020

Devic's Disease Trial in Chicago (Hematopoietic Stem Cell Transplantation, Cyclophosphamide, G-CSF)

Completed
  • Devic's Disease
  • Hematopoietic Stem Cell Transplantation
  • +6 more
  • Chicago, Illinois
    Northwestern University, Feinberg School of Medicine
Feb 17, 2020

Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)

Recruiting
  • Membranous Nephropathy - PLA2R Induced
  • Rituximab, Cyclophosphamide, and Corticosteroids
  • Saint Petersburg, Russian Federation
    St. Petersburg State Pavlov Medical University
Jan 7, 2023

Diffuse Large B Cell Lymphoma Trial in Colchester, Canterbury, Nottingham (R-CHOP, R-CHOP + acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Colchester, Essex, United Kingdom
  • +32 more
Oct 25, 2022

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2021

Henoch-Schoenlein Purpura Nephritis Trial in Nanjing (Prednisone, Cyclophosphamide(CTX), Mycophenolate mofetil(MMF))

Unknown status
  • Henoch-Schoenlein Purpura Nephritis
  • Nanjing, Jiangsu, China
    Nanjing Children's Hospital
Feb 25, 2020

Idiopathic Membranous Nephropathy Trial in Beijing (Rituximab, Modified Ponticelli regimen)

Recruiting
  • Idiopathic Membranous Nephropathy
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 23, 2023

Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma, Ann Arbor Stage IVA Hodgkin Lymphoma Trial in

Active, not recruiting
  • Ann Arbor Stage IIB Hodgkin Lymphoma
  • +5 more
  • Bleomycin Sulfate
  • +11 more
  • Birmingham, Alabama
  • +198 more
Sep 16, 2022

Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

Recruiting
  • Chronic Myeloid Leukemia (CML)
  • +5 more
  • CliniMACS CD34+ Reagent System
  • +8 more
  • New York, New York
    Columbia University Medical Center
Jun 17, 2020

GVHD, Leukemia, Lymphoma Trial in Minneapolis (anti-thymocyte globulin, cyclophosphamide, cyclosporine)

Withdrawn
  • Graft Versus Host Disease
  • +2 more
  • anti-thymocyte globulin
  • +7 more
  • Minneapolis, Minnesota
    University of Minnesota Cancer Center
Dec 31, 2019

Anti-Glomerular Basement Membrane Antibody Disease Trial in Worldwide (Imlifidase)

Completed
  • Anti-Glomerular Basement Membrane Antibody Disease
  • Imlifidase
  • Innsbruck, Austria
  • +9 more
Feb 7, 2022

Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow

Recruiting
  • Renal Failure
  • Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
  • Combined bone marrow and kidney transplant
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 19, 2023

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +11 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 29, 2020

Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)

Not yet recruiting
  • Kidney Failure
  • +2 more
  • Bone Marrow Transplant
  • +2 more
  • (no location specified)
Jun 9, 2023